603707 健友股份
已收盘 10-18 15:00:00
资讯
新帖
简况
健友股份大幅上涨 获6家券商给予增持建议
智选洞察 · 10-18 14:25
健友股份大幅上涨 获6家券商给予增持建议
健友股份大幅上涨 获主力净流入1869万元
智选洞察 · 10-17 10:06
健友股份大幅上涨 获主力净流入1869万元
健友股份:注射用泮托拉唑钠获批
证券 · 10-14
健友股份:注射用泮托拉唑钠获批
健友股份:产品取得注册证
每日经济新闻 · 10-14
健友股份:产品取得注册证
健友股份(603707.SH)获得注射用泮托拉唑钠药品注册批件
智通财经 · 10-14
健友股份(603707.SH)获得注射用泮托拉唑钠药品注册批件
健友股份大幅上涨 获主力净流入114万元
智选洞察 · 10-14
健友股份大幅上涨 获主力净流入114万元
健友股份:融资净偿还125.63万元,融资余额8376.86万元(10-11)
东方财富 · 10-12
健友股份:融资净偿还125.63万元,融资余额8376.86万元(10-11)
健友股份大跌5.35% 6家券商给予增持建议
智选洞察 · 10-11
健友股份大跌5.35% 6家券商给予增持建议
健友股份:融资净偿还212.64万元,融资余额7924.17万元(10-09)
东方财富 · 10-10
健友股份:融资净偿还212.64万元,融资余额7924.17万元(10-09)
健友股份:融资净买入161.92万元,融资余额8052.63万元(10-08)
东方财富 · 10-09
健友股份:融资净买入161.92万元,融资余额8052.63万元(10-08)
天风证券:给予健友股份买入评级,目标价位18.15元
证券之星 · 10-08
天风证券:给予健友股份买入评级,目标价位18.15元
天风证券给予健友股份买入评级 海外制剂业务持续发展 生物药启航在即 目标价格为18.15元
每日经济新闻 · 10-08
天风证券给予健友股份买入评级 海外制剂业务持续发展 生物药启航在即 目标价格为18.15元
健友股份触及涨停 创近9个月新高
智选洞察 · 10-08
健友股份触及涨停 创近9个月新高
9月30日健友股份涨7.30%,景顺长城策略精选灵活配置混合A基金重仓该股
证券之星 · 09-30
9月30日健友股份涨7.30%,景顺长城策略精选灵活配置混合A基金重仓该股
健友股份涨7.30%,中国银河三周前给出“买入”评级
证券之星 · 09-30
健友股份涨7.30%,中国银河三周前给出“买入”评级
健友股份09月30日获主力加仓1411万元 环比增加578.37%
市场透视 · 09-30
健友股份09月30日获主力加仓1411万元 环比增加578.37%
健友股份创7个月新高 7家券商给予增持建议
智选洞察 · 09-30
健友股份创7个月新高 7家券商给予增持建议
健友股份:融资净偿还46.88万元,融资余额6626.23万元(09-27)
东方财富 · 09-30
健友股份:融资净偿还46.88万元,融资余额6626.23万元(09-27)
健友股份:融资净买入179.76万元,融资余额6525.43万元(09-25)
东方财富 · 09-26
健友股份:融资净买入179.76万元,融资余额6525.43万元(09-25)
健友股份:药房大包装氟尿嘧啶注射液ANDA申请获批
东方财富 · 09-25
健友股份:药房大包装氟尿嘧啶注射液ANDA申请获批
加载更多
公司概况
公司名称:
南京健友生化制药股份有限公司
所属行业:
医药制造业
上市日期:
2017-07-19
主营业务:
南京健友生化制药股份有限公司主营业务是药品原料、制剂的研发、生产和销售。公司的主要产品包括肝素钠注射液、依诺肝素钠注射液、达肝素钠注射液等。公司秉承“建设世界一流的生物制药企业”的愿景,在“立足中美,放眼全球”的战略框架下,以注射剂为核心剂型,持续推进经营业务发展。通过对全球制剂业务的不断探索,公司在注射剂方向上广泛布局、积累了丰富的产品管线,主要包括低分子肝素制剂、抗肿瘤制剂及其他高附加值无菌注射剂,截至报告期末,公司及子公司共拥有97项境外药品注册批件,28项中国药品注册批件。
发行价格:
7.21
{"stockData":{"symbol":"603707","market":"SH","secType":"STK","nameCN":"健友股份","latestPrice":15.61,"timestamp":1729234800000,"preClose":14.91,"halted":0,"volume":15492414,"delay":0,"floatShares":1616000000,"shares":1616000000,"eps":-0.2532,"marketStatus":"已收盘","marketStatusCode":5,"change":0.7,"latestTime":"10-18 15:00:00","open":14.76,"high":15.86,"low":14.72,"amount":239000000,"amplitude":0.0765,"askPrice":15.62,"askSize":32,"bidPrice":15.61,"bidSize":618,"shortable":0,"etf":0,"ttmEps":-0.2532,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1729474200000},"adr":0,"adjPreClose":14.91,"symbolType":"stock","openAndCloseTimeList":[[1729215000000,1729222200000],[1729227600000,1729234800000]],"highLimit":16.4,"lowLimit":13.42,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1615634520,"pbRate":4.19,"roa":"--","roe":"6.91%","epsLYR":-0.12,"committee":0.650733,"marketValue":25220000000,"floatMarketCap":25220000000,"peRate":-61.65087,"changeRate":0.0469,"turnoverRate":0.0096,"status":0,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2024-10-21。"},"requestUrl":"/m/hq/s/603707","defaultTab":"news","newsList":[{"id":"2476424290","title":"健友股份大幅上涨 获6家券商给予增持建议","url":"https://stock-news.laohu8.com/highlight/detail?id=2476424290","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476424290?lang=zh_cn&edition=full","pubTime":"2024-10-18 14:25","pubTimestamp":1729232700,"startTime":"0","endTime":"0","summary":"10月18日,健友股份股价大幅上涨,截至14点25分,健友股份上涨5.03%,报15.66元/股,成交1.86亿元,换手率0.75%。此外,数据统计显示,近半年内6家券商给予增持建议,10家券商给予买入建议。资金动向截止发稿,健友股份获得主力净流出36万元,其中超大单流出375万元,大单流入340万元。最新财报显示,今年中报,健友股份实现营业收入21.43亿元,同比减少6.99%,净利润为4.05亿元,同比减少35.15%,基本每股收益为0.25元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018144544a1e1a0ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018144544a1e1a0ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0186","603707","BK0239","BK0046"],"gpt_icon":0},{"id":"2476852150","title":"健友股份大幅上涨 获主力净流入1869万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476852150","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476852150?lang=zh_cn&edition=full","pubTime":"2024-10-17 10:06","pubTimestamp":1729130803,"startTime":"0","endTime":"0","summary":"10月17日,健友股份股价大幅上涨,截至10点06分,健友股份上涨5.15%,报15.51元/股,成交9214万元,换手率0.37%,振幅4.95%。资金动向截止发稿,健友股份获得主力净流入1869万元,其中超大单流入1798万元,大单流入71万元。数据显示,该股今日净流入较近5日净流入均值增加2248万元。最新财报显示,今年中报,健友股份实现营业收入21.43亿元,同比减少6.99%,净利润为4.05亿元,同比减少35.15%,基本每股收益为0.25元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017132908ab6abb9b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017132908ab6abb9b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603707","BK0186","BK0046"],"gpt_icon":0},{"id":"2475449354","title":"健友股份:注射用泮托拉唑钠获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2475449354","media":"证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475449354?lang=zh_cn&edition=full","pubTime":"2024-10-14 18:38","pubTimestamp":1728902280,"startTime":"0","endTime":"0","summary":"证券日报网讯10月14日晚间,健友股份发布公告称,公司近日收到国家药品监督管理局签发的注射用泮托拉唑钠40mg规格的药品注册证书,药品批准文号为国药准字H20249036。注射用泮托拉唑钠适用于十二指肠溃疡、胃溃疡等,公司在该药品研发项目上已投入研发费用约人民币2592.31万元。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2024-10-14/doc-incspmqw8185520.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2024-10-14/doc-incspmqw8185520.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["603707","BK0046","BK0239","BK0186"],"gpt_icon":0},{"id":"2475355026","title":"健友股份:产品取得注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2475355026","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475355026?lang=zh_cn&edition=full","pubTime":"2024-10-14 17:47","pubTimestamp":1728899256,"startTime":"0","endTime":"0","summary":"每经AI快讯,健友股份(SH 603707,收盘价:14.68元)10月14日晚间发布公告称,南京健友生化制药股份有限公司于近日收到国家药品监督管理局签发的注射用泮托拉唑钠40mg规格的药品注册证书。产品名称为“注射用泮托拉唑钠”。2023年1至12月份,健友股份的营业收入构成为:医药制造行业占比99.78%。截至发稿,健友股份市值为237亿元。道达号(daoda1997)“个股趋势”提醒:1. 近30日内无机构对健友股份进行调研。每经头条(nbdtoutiao)——避雷还是低吸?170余只减持股大揭秘,有一类减持股形成投资机会(记者 曾健辉)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101417480395a6d2a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101417480395a6d2a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0046","BK0239","603707","BK0186"],"gpt_icon":0},{"id":"2475635351","title":"健友股份(603707.SH)获得注射用泮托拉唑钠药品注册批件","url":"https://stock-news.laohu8.com/highlight/detail?id=2475635351","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475635351?lang=zh_cn&edition=full","pubTime":"2024-10-14 17:27","pubTimestamp":1728898025,"startTime":"0","endTime":"0","summary":"智通财经APP讯,健友股份 发布公告,公司于近日收到国家药品监督管理局签发的注射用泮托拉唑钠40mg规格的药品注册证书。公司注射用泮托拉唑钠获得国家药监局的药品注册证书,标志着公司具备了在国内市场销售该药品的资格,进一步丰富了公司的产品线,有助于提升公司产品的市场竞争力。根据国家相关政策,注射用泮托拉唑钠按化学药品4类批准生产,视同通过一致性评价,有望对公司经营业绩产生积极的影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1193483.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0186","BK0046","BK0239","603707"],"gpt_icon":0},{"id":"2475282807","title":"健友股份大幅上涨 获主力净流入114万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475282807","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475282807?lang=zh_cn&edition=full","pubTime":"2024-10-14 11:12","pubTimestamp":1728875544,"startTime":"0","endTime":"0","summary":"10月14日,健友股份股价大幅上涨,截至11点12分,健友股份上涨5.00%,报14.49元/股,成交9080万元,换手率0.40%,振幅5.51%。资金动向截止发稿,健友股份获得主力净流入114万元,其中超大单流入12万元,大单流入101万元。数据显示,该股今日净流入较近5日净流入均值增加618万元。最新财报显示,今年中报,健友股份实现营业收入21.43亿元,同比减少6.99%,净利润为4.05亿元,同比减少35.15%,基本每股收益为0.25元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241014111229a1e0680e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241014111229a1e0680e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0046","603707","BK0239","BK0186"],"gpt_icon":0},{"id":"2474024700","title":"健友股份:融资净偿还125.63万元,融资余额8376.86万元(10-11)","url":"https://stock-news.laohu8.com/highlight/detail?id=2474024700","media":"东方财富","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474024700?lang=zh_cn&edition=full","pubTime":"2024-10-12 07:33","pubTimestamp":1728689580,"startTime":"0","endTime":"0","summary":"健友股份融资融券信息显示,2024年10月11日融资净偿还125.63万元;融资余额8376.86万元,较前一日下降1.48%。融资方面,当日融资买入400.55万元,融资偿还526.18万元,融资净偿还125.63万元。融券方面,融券卖出1000股,融券偿还3200股,融券余量13.01万股,融券余额179.59万元。融资融券余额合计8556.46万元。健友股份融资融券交易明细(10-11)健友股份历史融资融券数据一览免责声明:本文基于AI生产,仅供参考,不构成任何投资建议,据此操作风险自担。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2024-10-12/doc-incsfvxp0789148.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2024-10-12/doc-incsfvxp0789148.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0186","603707","BK0239","BK0046"],"gpt_icon":0},{"id":"2474584310","title":"健友股份大跌5.35% 6家券商给予增持建议","url":"https://stock-news.laohu8.com/highlight/detail?id=2474584310","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474584310?lang=zh_cn&edition=full","pubTime":"2024-10-11 14:35","pubTimestamp":1728628557,"startTime":"0","endTime":"0","summary":"10月11日,健友股份股价大幅下跌,截至14点35分,健友股份下跌5.35%,报13.62元/股,成交1.08亿元,换手率0.48%,振幅5.56%。此外,数据统计显示,近半年内6家券商给予增持建议,10家券商给予买入建议。最新财报显示,今年中报,健友股份实现营业收入21.43亿元,同比减少6.99%,净利润为4.05亿元,同比减少35.15%,基本每股收益为0.25元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241011145023a1dfe964&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241011145023a1dfe964&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0046","BK0186","BK0239","603707"],"gpt_icon":0},{"id":"2474669782","title":"健友股份:融资净偿还212.64万元,融资余额7924.17万元(10-09)","url":"https://stock-news.laohu8.com/highlight/detail?id=2474669782","media":"东方财富","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474669782?lang=zh_cn&edition=full","pubTime":"2024-10-10 07:45","pubTimestamp":1728517500,"startTime":"0","endTime":"0","summary":"健友股份融资融券信息显示,2024年10月9日融资净偿还212.64万元;融资余额7924.17万元,较前一日下降1.6%。融资方面,当日融资买入988.85万元,融资偿还1201.49万元,融资净偿还212.64万元。融券方面,融券卖出900股,融券偿还7000股,融券余量13.18万股,融券余额191.04万元。融资融券余额合计8115.2万元。健友股份融资融券交易明细(10-09)健友股份历史融资融券数据一览免责声明:本文基于AI生产,仅供参考,不构成任何投资建议,据此操作风险自担。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2024-10-10/doc-incrzisz2487509.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2024-10-10/doc-incrzisz2487509.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","603707","BK0046","BK0186"],"gpt_icon":0},{"id":"2474258235","title":"健友股份:融资净买入161.92万元,融资余额8052.63万元(10-08)","url":"https://stock-news.laohu8.com/highlight/detail?id=2474258235","media":"东方财富","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474258235?lang=zh_cn&edition=full","pubTime":"2024-10-09 07:32","pubTimestamp":1728430320,"startTime":"0","endTime":"0","summary":"健友股份融资融券信息显示,2024年10月8日融资净买入161.92万元;融资余额8052.63万元,较前一日增加2.05%。融资方面,当日融资买入2074.45万元,融资偿还1912.53万元,融资净买入161.92万元。融券方面,融券卖出600股,融券偿还3.08万股,融券余量13.79万股,融券余额208.15万元。融资融券余额合计8260.79万元。健友股份融资融券交易明细(10-08)健友股份历史融资融券数据一览免责声明:本文基于AI生产,仅供参考,不构成任何投资建议,据此操作风险自担。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2024-10-09/doc-incrxeuc0083596.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2024-10-09/doc-incrxeuc0083596.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0186","BK0046","BK0239","603707"],"gpt_icon":0},{"id":"2473153644","title":"天风证券:给予健友股份买入评级,目标价位18.15元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473153644","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473153644?lang=zh_cn&edition=full","pubTime":"2024-10-08 14:59","pubTimestamp":1728370762,"startTime":"0","endTime":"0","summary":"天风证券股份有限公司杨松近期对健友股份进行研究并发布了研究报告《海外制剂业务持续发展,生物药启航在即》,本报告对健友股份给出买入评级,认为其目标价位为18.15元,当前股价为15.08元,预期上涨幅度为20.36%。首次覆盖,给予“买入”评级。最新盈利预测明细如下:该股最近90天内共有11家机构给出评级,买入评级7家,增持评级4家;过去90天内机构目标均价为15.67。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024100800016639.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601162","603707"],"gpt_icon":0},{"id":"2473494423","title":"天风证券给予健友股份买入评级 海外制剂业务持续发展 生物药启航在即 目标价格为18.15元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473494423","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473494423?lang=zh_cn&edition=full","pubTime":"2024-10-08 13:48","pubTimestamp":1728366480,"startTime":"0","endTime":"0","summary":"天风证券10月08日发布研报称,给予健友股份(603707.SH)买入评级,目标价格为18.15元。评级理由主要包括:1)肝素原料药:全球肝素原料龙头,价格逐步企稳;2)制剂:注射剂国际化能力领先,驱动业绩高速成长;3)生物药:多元化高效切入生物药市场,有望带动业绩加速增长。风险提示:原料药价格波动风险、无菌注射剂开发与审批波动风险、海外市场竞争风险、新药研发、上市进度不及预期风险、监管风险。AI点评:健友股份近一个月获得1份券商研报关注,买入1家,平均目标价为18.15元。(文章来源:每日经济新闻)\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2024-10-08/doc-incrvnkx0816685.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2024-10-08/doc-incrvnkx0816685.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["603707","159839","601162"],"gpt_icon":0},{"id":"2473468345","title":"健友股份触及涨停 创近9个月新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2473468345","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473468345?lang=zh_cn&edition=full","pubTime":"2024-10-08 09:30","pubTimestamp":1728351003,"startTime":"0","endTime":"0","summary":"10月08日,健友股份股价大幅上涨,截至09点30分,健友股份触及涨停,报16.01元/股,创近9个月新高,成交253万元,换手率0.01%。资金动向截止发稿,健友股份获得主力净流出280万元,其中超大单流出208万元,大单流出70万元。主营业务及业绩健友股份公司主营业务为药品原料、制剂的研发、生产和销售。最新财报显示,今年中报,健友股份实现营业收入21.43亿元,同比减少6.99%,净利润为4.05亿元,同比减少35.15%,基本每股收益为0.25元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241008094800ab683bf0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241008094800ab683bf0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0046","603707","BK0239","BK0186"],"gpt_icon":0},{"id":"2471879954","title":"9月30日健友股份涨7.30%,景顺长城策略精选灵活配置混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2471879954","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471879954?lang=zh_cn&edition=full","pubTime":"2024-09-30 17:26","pubTimestamp":1727688381,"startTime":"0","endTime":"0","summary":"根据2024基金半年报公募基金重仓股数据,重仓该股的公募基金共8家,其中持有数量最多的公募基金为景顺长城策略精选灵活配置混合A。景顺长城策略精选灵活配置混合A目前规模为43.09亿元,最新净值2.824,较上一交易日上涨3.44%,近一年上涨0.25%。景顺长城策略精选灵活配置混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024093000030308.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603707","BK0186","BK0239","BK0046"],"gpt_icon":0},{"id":"2471626879","title":"健友股份涨7.30%,中国银河三周前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2471626879","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471626879?lang=zh_cn&edition=full","pubTime":"2024-09-30 17:26","pubTimestamp":1727688376,"startTime":"0","endTime":"0","summary":"今日健友股份涨7.30%,收盘报14.55元。2024年9月3日,中国银河研究员程培,孙怡发布了对健友股份的研报《2024年中报业绩点评:Q2业绩环比改善,海外非肝素制剂快速放量》,该研报对健友股份给出“买入”评级。研报中预计公司2024-2026年归母净利润为9.08/13.98/18.74亿元,同比增长579%/54%/34%,当前股价对应2024-2025年PE为20/13/10倍,维持“推荐”评级。健友股份个股概况:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024093000030305.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601881","603707"],"gpt_icon":0},{"id":"2471821528","title":"健友股份09月30日获主力加仓1411万元 环比增加578.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2471821528","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471821528?lang=zh_cn&edition=full","pubTime":"2024-09-30 15:17","pubTimestamp":1727680652,"startTime":"0","endTime":"0","summary":"09月30日, 健友股份股价涨7.30%,报收14.55元,成交金额2.18亿元,换手率0.94%,振幅6.42%,量比1.99。健友股份今日主力资金净流入1411万元,连续3日净流入,上一交易日主力净流入208万元,今日环比增加578.37%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为53.85%,平均涨幅为1.81%。该股近5个交易日上涨15.75%,主力资金累计净流入2177万元;近20日主力资金累计净流出4264万元,其中净流出天数为11日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024093015223795877189&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024093015223795877189&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603707","BK0186","BK0046"],"gpt_icon":0},{"id":"2471508816","title":"健友股份创7个月新高 7家券商给予增持建议","url":"https://stock-news.laohu8.com/highlight/detail?id=2471508816","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471508816?lang=zh_cn&edition=full","pubTime":"2024-09-30 09:32","pubTimestamp":1727659977,"startTime":"0","endTime":"0","summary":"09月30日,健友股份股价大幅上涨,截至09点32分,健友股份上涨5.16%,报14.26元/股,创近7个月新高,成交947万元,换手率0.04%,振幅1.70%。此外,数据统计显示,近半年内7家券商给予增持建议,9家券商给予买入建议。融资融券方面,健友股份09月26日获得融资净买入147万元,当日该股融资余额为6673万元,当较前一日增加2.26%,实现3连增;该股融券余额为311万元,融券余量为21.82万股,比上日增加4.30%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240930095148a1dd79f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240930095148a1dd79f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0046","BK0239","BK0186","603707"],"gpt_icon":0},{"id":"2471892876","title":"健友股份:融资净偿还46.88万元,融资余额6626.23万元(09-27)","url":"https://stock-news.laohu8.com/highlight/detail?id=2471892876","media":"东方财富","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471892876?lang=zh_cn&edition=full","pubTime":"2024-09-30 08:05","pubTimestamp":1727654700,"startTime":"0","endTime":"0","summary":"健友股份融资融券信息显示,2024年9月27日融资净偿还46.88万元;融资余额6626.23万元,较前一日下降0.7%。融资方面,当日融资买入309.52万元,融资偿还356.4万元,融资净偿还46.88万元。融券方面,融券卖出1300股,融券偿还1000股,融券余量21.85万股,融券余额296.34万元。融资融券余额合计6922.57万元。健友股份融资融券交易明细(09-27)健友股份历史融资融券数据一览免责声明:本文基于AI生产,仅供参考,不构成任何投资建议,据此操作风险自担。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2024-09-30/doc-incqwusy5254947.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2024-09-30/doc-incqwusy5254947.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0186","BK0046","BK0239","603707"],"gpt_icon":0},{"id":"2470124396","title":"健友股份:融资净买入179.76万元,融资余额6525.43万元(09-25)","url":"https://stock-news.laohu8.com/highlight/detail?id=2470124396","media":"东方财富","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470124396?lang=zh_cn&edition=full","pubTime":"2024-09-26 07:44","pubTimestamp":1727307840,"startTime":"0","endTime":"0","summary":"健友股份融资融券信息显示,2024年9月25日融资净买入179.76万元;融资余额6525.43万元,较前一日增加2.83%。融资方面,当日融资买入263.17万元,融资偿还83.41万元,融资净买入179.76万元。融券方面,融券卖出1900股,融券偿还1.28万股,融券余量20.92万股,融券余额269.92万元。融资融券余额合计6795.35万元。健友股份融资融券交易明细(09-25)健友股份历史融资融券数据一览免责声明:本文基于AI生产,仅供参考,不构成任何投资建议,据此操作风险自担。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2024-09-26/doc-incqmuhz4783543.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2024-09-26/doc-incqmuhz4783543.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","603707","BK0186","BK0046"],"gpt_icon":0},{"id":"2470234187","title":"健友股份:药房大包装氟尿嘧啶注射液ANDA申请获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2470234187","media":"东方财富","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470234187?lang=zh_cn&edition=full","pubTime":"2024-09-25 18:07","pubTimestamp":1727258820,"startTime":"0","endTime":"0","summary":"中证智能财讯健友股份9月25日晚间公告,公司子公司健进制药有限公司于近日收到美国食品药品监督管理局签发的氟尿嘧啶注射液,2.5g/50mL 药房大包装的ANDA批准通知。经查询,当前美国现有6家公司同规格氟尿嘧啶注射液仿制药在市销售。截至目前,公司在该规格氟尿嘧啶注射液研发项目上已投入研发费用约1275.68万元。资料显示,ANDA,简略新药申请或仿制药注册申请,是FDA用于审核和批准仿制药的一种流程。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2024-09-25/doc-incqknph8235682.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2024-09-25/doc-incqknph8235682.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0046","603707","BK0239","BK0186"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2017-07-19","address":"江苏省南京市浦口区高新开发区MA010-1号地","stockEarnings":[{"period":"1week","weight":0.1312},{"period":"1month","weight":0.2026},{"period":"3month","weight":0.3229},{"period":"6month","weight":0.2925},{"period":"1year","weight":0.2936},{"period":"ytd","weight":0.0495}],"companyName":"南京健友生化制药股份有限公司","boardCode":"AI0027","perCapita":"91103股","boardName":"医药制造业","registeredCapital":"161563万元","compareEarnings":[{"period":"1week","weight":0.0136},{"period":"1month","weight":0.2003},{"period":"3month","weight":0.0936},{"period":"6month","weight":0.064},{"period":"1year","weight":0.0852},{"period":"ytd","weight":0.0963}],"survey":" 南京健友生化制药股份有限公司主营业务是药品原料、制剂的研发、生产和销售。公司的主要产品包括肝素钠注射液、依诺肝素钠注射液、达肝素钠注射液等。公司秉承“建设世界一流的生物制药企业”的愿景,在“立足中美,放眼全球”的战略框架下,以注射剂为核心剂型,持续推进经营业务发展。通过对全球制剂业务的不断探索,公司在注射剂方向上广泛布局、积累了丰富的产品管线,主要包括低分子肝素制剂、抗肿瘤制剂及其他高附加值无菌注射剂,截至报告期末,公司及子公司共拥有97项境外药品注册批件,28项中国药品注册批件。","serverTime":1729335907285,"listedPrice":7.21,"stockholders":"17734人(较上一季度减少28.39%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.0","shortVersion":"4.29.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"健友股份(603707)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供健友股份(603707)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"健友股份,603707,健友股份股票,健友股份股票老虎,健友股份股票老虎国际,健友股份行情,健友股份股票行情,健友股份股价,健友股份股市,健友股份股票价格,健友股份股票交易,健友股份股票购买,健友股份股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"健友股份(603707)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供健友股份(603707)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}